Fairmount Funds Management LLC Diversified Active

Location: West Conshohocken, PA

CIK: 0001802528 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 13, 2021

Total Value: $243M (100.0% shares, 0.0% debt)

Holdings (19)

INSM INSMED INC 15.0%

Value $36.54M Shares 1,283,887 Est. Cost $23.03 Unrealized +28.9%

— ZOGENIX INC 14.0%

Value $34.05M Shares 1,970,259 Est. Cost $27.22 Unrealized —

AXSM AXSOME THERAPEUTICS INC 8.7%

Value $21.09M Shares 312,598 Est. Cost $75.74 Unrealized -20.8%

ARGX ARGENX SE 8.6%

Value $20.82M Shares 69,144 Est. Cost $198.98 Unrealized —

IOVA IOVANCE BIOTHERAPEUTICS INC 5.4%

Value $13.16M Shares 505,890 Est. Cost $24.87 Unrealized +4.5%

— INSTIL BIO INC 5.4%

Value $13.02M Shares 673,905 Est. Cost $24.02 Unrealized —

— ALLAKOS INC 5.3%

Value $12.99M Shares 152,162 Est. Cost $81.25 Unrealized —

COGT COGENT BIOSCIENCES INC 5.2%

Value $12.64M Shares 1,558,975 Est. Cost $10.99 Unrealized -23.1%

— AMARIN CORP PLC 4.6%

Value $11.1M Shares 2,533,237 Est. Cost $10.64 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 4.2%

Value $10.34M Shares 423,817 Est. Cost $43.17 Unrealized -47.7%

— THERAPEUTICS ACQUISITION COR 3.6%

Value $8.875M Shares 864,214 Est. Cost $10.28 Unrealized —

— TRILLIUM THERAPEUTICS INC 3.6%

Value $8.694M Shares 896,281 Est. Cost $4.53 Unrealized —

— CATABASIS PHARMACEUTICALS IN 3.5%

Value $8.634M Shares 4,092,166 Est. Cost $2.12 Unrealized —

FOLD AMICUS THERAPEUTICS INC 3.5%

Value $8.57M Shares 888,980 Est. Cost $9.80 Unrealized -0.3%

ENTA ENANTA PHARMACEUTICALS INC 3.2%

Value $7.836M Shares 178,058 Est. Cost $59.73 Unrealized -18.0%

— GLOBAL BLOOD THERAPEUTICS IN 3.0%

Value $7.354M Shares 210,000 Est. Cost $41.93 Unrealized —

KROS KEROS THERAPEUTICS INC 2.6%

Value $6.342M Shares 149,333 Est. Cost $60.90 Unrealized -11.0%

VRDN VIRIDIAN THERAPEUTICS INC 0.3%

Value $642K Shares 35,092 Est. Cost $18.72 Unrealized -8.6%

— VERONA PHARMA PLC 0.2%

Value $549K Shares 83,944 Est. Cost $6.24 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INSM	INSMED INC	1,283,887	$36.54M	15.0%	$23.03	+28.9%	COM PAR $.01	457669307
—	ZOGENIX INC	1,970,259	$34.05M	14.0%	$27.22	—	COM NEW	98978L204
AXSM	AXSOME THERAPEUTICS INC	312,598	$21.09M	8.7%	$75.74	-20.8%	COM	05464T104
ARGX	ARGENX SE	69,144	$20.82M	8.6%	$198.98	—	SPONSORED ADR	04016X101
IOVA	IOVANCE BIOTHERAPEUTICS INC	505,890	$13.16M	5.4%	$24.87	+4.5%	COM	462260100
—	INSTIL BIO INC	673,905	$13.02M	5.4%	$24.02	—	COM	45783C101
—	ALLAKOS INC	152,162	$12.99M	5.3%	$81.25	—	COM	01671P100
COGT	COGENT BIOSCIENCES INC	1,558,975	$12.64M	5.2%	$10.99	-23.1%	COM	19240Q201
—	AMARIN CORP PLC	2,533,237	$11.1M	4.6%	$10.64	—	SPONS ADR NEW	023111206
ACAD	ACADIA PHARMACEUTICALS INC	423,817	$10.34M	4.2%	$43.17	-47.7%	COM	004225108
—	THERAPEUTICS ACQUISITION COR	864,214	$8.875M	3.6%	$10.28	—	COM CL A	88339T103
—	TRILLIUM THERAPEUTICS INC	896,281	$8.694M	3.6%	$4.53	—	COM NEW	89620X506
—	CATABASIS PHARMACEUTICALS IN	4,092,166	$8.634M	3.5%	$2.12	—	COM NEW	14875P206
FOLD	AMICUS THERAPEUTICS INC	888,980	$8.57M	3.5%	$9.80	-0.3%	COM	03152W109
ENTA	ENANTA PHARMACEUTICALS INC	178,058	$7.836M	3.2%	$59.73	-18.0%	COM	29251M106
—	GLOBAL BLOOD THERAPEUTICS IN	210,000	$7.354M	3.0%	$41.93	—	COM	37890U108
KROS	KEROS THERAPEUTICS INC	149,333	$6.342M	2.6%	$60.90	-11.0%	COM	492327101
VRDN	VIRIDIAN THERAPEUTICS INC	35,092	$642K	0.3%	$18.72	-8.6%	COM	92790C104
—	VERONA PHARMA PLC	83,944	$549K	0.2%	$6.24	—	SPONSORED ADS	925050106